IGL Trials

IGL is undertaking and supporting a number of randomised controlled trials globally.

Why does growth stall in high-growth potential, second-stage companies, and can we intervene to overcome this?

This research seeks to address why growth rates so often peter out in adolescent firms, and why so few make it to “grownup” status.

Is there an effect of incubator spaces on the survival of startups and their economic performance? And if so, why?

Can a more focused, mini-accelerator programme be an effective and low-cost approach to increase startups’ growth?

What is the impact of different types of knowledge transfer activities on the number and quality of business-science interactions?

What is the impact of different types of entrepreneurial training programmes?

How do different types of proximity impact collaboration and knowledge generation? How should we design research campuses to maximize the probability of breakthrough innovation taking place?


Subscribe to IGL projects